
### [MONDO:0020077](http://purl.obolibrary.org/obo/MONDO_0020077)
**Label:** myelodysplastic/myeloproliferative disease

**Subclasses:** [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0020311](http://purl.obolibrary.org/obo/MONDO_0020311) (chronic myelomonocytic leukemia), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), 

**Corr. equiv. classes:** [Orphanet:98823](http://www.orpha.net/ORDO/Orphanet_98823), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), 

**Class expressions from DL-Learner:**

- [HP:0006721](http://purl.obolibrary.org/obo/HP_0006721) (Acute lymphoblastic leukemia) 62.50%
- [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) 62.50%
- [HP:0001912](http://purl.obolibrary.org/obo/HP_0001912) (Abnormality of basophils) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and [HP:0006721](http://purl.obolibrary.org/obo/HP_0006721) (Acute lymphoblastic leukemia) 62.50%
- [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) and [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) 62.50%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) 62.50%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology))) 62.50%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology))) 62.50%


